Skip to main content
FDA OKs Sunovion's inhalation solution for COPD
12/6/2017

Sunovion's Lonhala Magnair inhalation solution was approved by the FDA as a treatment for patients with chronic obstructive pulmonary disease. The company intends to launch the drug in early 2018.

Full Story: